Geode Capital Management
JAZZ icon

Geode Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$124M Buy
1,171,755
+16,757
+1% +$1.78M 0.01% 889
2025
Q1
$143M Buy
1,154,998
+61,556
+6% +$7.64M 0.01% 771
2024
Q4
$135M Sell
1,093,442
-21,336
-2% -$2.63M 0.01% 812
2024
Q3
$124M Sell
1,114,778
-83
-0% -$9.25K 0.01% 846
2024
Q2
$119M Buy
1,114,861
+7,551
+0.7% +$806K 0.01% 810
2024
Q1
$133M Buy
1,107,310
+57,922
+6% +$6.97M 0.01% 761
2023
Q4
$129M Buy
1,049,388
+36,641
+4% +$4.5M 0.01% 722
2023
Q3
$131M Buy
1,012,747
+14,680
+1% +$1.9M 0.02% 655
2023
Q2
$124M Buy
998,067
+44,286
+5% +$5.48M 0.01% 679
2023
Q1
$139M Buy
953,781
+17,166
+2% +$2.51M 0.02% 599
2022
Q4
$149M Buy
936,615
+61,364
+7% +$9.77M 0.02% 566
2022
Q3
$117M Sell
875,251
-15,276
-2% -$2.03M 0.02% 626
2022
Q2
$139M Sell
890,527
-1,773
-0.2% -$276K 0.02% 580
2022
Q1
$139M Sell
892,300
-83,574
-9% -$13M 0.02% 636
2021
Q4
$124M Buy
975,874
+57,988
+6% +$7.38M 0.02% 712
2021
Q3
$119M Sell
917,886
-80,768
-8% -$10.5M 0.02% 698
2021
Q2
$177M Buy
998,654
+88,386
+10% +$15.7M 0.02% 571
2021
Q1
$149M Buy
910,268
+137,574
+18% +$22.6M 0.02% 597
2020
Q4
$127M Sell
772,694
-60,345
-7% -$9.95M 0.02% 603
2020
Q3
$119M Sell
833,039
-27,368
-3% -$3.9M 0.02% 553
2020
Q2
$94.9M Sell
860,407
-6,165
-0.7% -$680K 0.02% 586
2020
Q1
$86.4M Buy
866,572
+11,431
+1% +$1.14M 0.02% 549
2019
Q4
$128M Buy
855,141
+66,319
+8% +$9.89M 0.03% 523
2019
Q3
$101M Buy
788,822
+1,878
+0.2% +$241K 0.02% 562
2019
Q2
$112M Buy
786,944
+71,350
+10% +$10.2M 0.03% 532
2019
Q1
$102M Buy
715,594
+83,564
+13% +$11.9M 0.03% 543
2018
Q4
$78.3M Buy
632,030
+61,649
+11% +$7.64M 0.02% 558
2018
Q3
$95.8M Buy
570,381
+16,232
+3% +$2.73M 0.03% 542
2018
Q2
$95.4M Buy
554,149
+110,832
+25% +$19.1M 0.03% 532
2018
Q1
$66.9M Buy
443,317
+23,150
+6% +$3.49M 0.02% 615
2017
Q4
$56.5M Buy
420,167
+10,295
+3% +$1.39M 0.02% 659
2017
Q3
$59.9M Buy
409,872
+9,442
+2% +$1.38M 0.02% 597
2017
Q2
$62.2M Buy
400,430
+7,167
+2% +$1.11M 0.02% 570
2017
Q1
$57M Buy
393,263
+15,290
+4% +$2.22M 0.02% 585
2016
Q4
$41.2M Buy
377,973
+16,338
+5% +$1.78M 0.02% 664
2016
Q3
$43.9M Buy
361,635
+3,228
+0.9% +$392K 0.02% 610
2016
Q2
$50.6M Sell
358,407
-39,218
-10% -$5.54M 0.03% 534
2016
Q1
$51.9K Buy
397,625
+29,119
+8% +$3.8K 0.03% 518
2015
Q4
$51.8M Buy
368,506
+9,907
+3% +$1.39M 0.03% 513
2015
Q3
$47.6M Buy
358,599
+5,858
+2% +$778K 0.03% 516
2015
Q2
$62.1M Buy
352,741
+12,080
+4% +$2.13M 0.04% 469
2015
Q1
$58.8M Buy
340,661
+20,119
+6% +$3.47M 0.03% 479
2014
Q4
$52.5M Buy
320,542
+9,602
+3% +$1.57M 0.03% 490
2014
Q3
$49.9M Buy
310,940
+33,256
+12% +$5.34M 0.03% 478
2014
Q2
$40.8M Sell
277,684
-8,733
-3% -$1.28M 0.03% 541
2014
Q1
$39.7M Buy
286,417
+6,919
+2% +$960K 0.03% 531
2013
Q4
$35.4M Buy
279,498
+43,695
+19% +$5.53M 0.02% 549
2013
Q3
$21.7M Buy
235,803
+14,174
+6% +$1.3M 0.02% 662
2013
Q2
$15.2M Buy
+221,629
New +$15.2M 0.01% 749